Torsten Hechler

Company: Heidelberg Pharma Research GmbH

Job title: SVP ADC Research

Seminars:

ATACs: A New Payload Provides New Options for Cancer Therapy 4:00 pm

Discussing a payload with a new mode of action providing new options to fight cancer Understanding how the ATAC platform optimized the ADC technology for that unique payload Clinical update on HDP-101 targeting BCMA; the first ATAC which is now in dose escalation in myeloma patients Read more

day: Day Two PM